|
|
|
|
Vol. 17, Issue 7, 2963-2975, July 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,||,¶
,
,
,||,¶
Departments of *Oral Biology,
Biochemistry and Molecular Biology,
Genetics, Cell Biology, and Anatomy, and
Pathology and Microbiology, ||Eppley Institute for Research in Cancer and Allied Diseases, and ¶Eppley Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198-7696
Submitted December 13, 2005;
Revised March 14, 2006;
Accepted April 10, 2006
Monitoring Editor: Jean Schwarzbauer
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
6
1 integrin (Hodivala and Watt, 1994
3
1 integrin and reduced adhesion to ECM (Finnemann et al., 1995
1 and
3 integrins regulate the surface distribution and activity of N-cadherin in migrating neural crest cells (Monier-Gavelle and Duband, 1997
3
1 in this activity. Likewise, integrin
1 was shown to regulate the polarity and motility of epithelial cells by down-regulating cadherin function and activating Rac1 and RhoA (Gimond et al., 1999
When epithelial cells change their relative position within a tissue, they convert to motile fibroblastic cells. This phenomenon is referred to as an epithelial-to-mesenchyme transition (EMT) (Affolter et al., 2003
). EMT is often accompanied by loss of E-cadherin and increased expression of other cadherins, such as N-cadherin, K-cadherin, or R-cadherin, depending on the tissue type (Thiery, 2003
). When cancer cells invade adjacent tissues, they use a mechanism akin to EMT, and loss of E-cadherin expression in epithelial carcinomas is thought to be the primary reason for disruption of tight epithelial cellcell contacts and release of invasive tumor cells from the primary tumor (Thiery, 2002
; Wheelock and Johnson, 2003
). We have shown that, in addition to the loss of the invasion-suppressor E-cadherin, another adhesion molecule, N-cadherin, becomes up-regulated in invasive tumor cells (Islam et al., 1996
). N-cadherin promotes cell motility, which is critical to tumor invasion and metastasis (Nieman et al., 1999
; Hazan et al., 2000
) and E- to N-cadherin switching is one step in the formation of invasive tumorigenic cells (Cavallaro et al., 2002
; Christofori, 2003
). Furthermore, recent studies from our laboratory showed that cadherin switching is necessary for the increased cell motility that accompanies transforming growth factor
(TGF
)induced EMT in mammary epithelial cells (Maeda et al., 2005
).
Maintenance of epithelial tissues requires interactions with the stroma. In cancer, changes in the stroma drive invasion and metastasis, the hallmarks of malignancy (De Wever and Mareel, 2003
). In addition, during oncogenic transformation, integrin-mediated responses to ECM can result in loss of cell polarity, dedifferentiation of epithelial cells, and a switch to a more motile invasive phenotype (Keely et al., 1997
). Some cell lines, such as NBT-II, respond to inducers of EMT much more rapidly when they are cultured on type I collagen rather than on other substrata (Tucker et al., 1990
; Savagner, 2001
). Thus, it is clear that when cells undergo phenotypic changes such as EMT, they must coordinate changes in cellcell interactions, such as cadherin switching, with changes in cellsubstrate interactions. Our hypothesis for the current study was that integrin-mediated cell motility must be coordinated with N-cadherin up-regulation through EMT-related signaling pathways.
| MATERIALS AND METHODS |
|---|
|
|
|---|
1, anti-paxillin, anti-Rac, anti-focal adhesion kinase (FAK), anti-Cdc42, anti-phosphotyrosine (PY20), anti-smad2/3, and anti-Akt mouse mAbs were from BD Biosciences PharMingen, Bedford, MA. Anti-FAK phospho-specific (Tyr577) and anti-c-Jun NH2-terminal kinase (JNK) phospho-specific (Thr183/Tyr185) rabbit polyclonal antibodies (pAbs) were from BioSource (Camarillo, CA). Anti-Src family phospho-specific (Tyr416) and anti-Akt phospho-specific (Thr308) rabbit pAbs were from Cell Signaling Technology (Beverly, MA). Anti-Src mouse mAb (clone 327) was from Oncogene Research Products (San Diego, CA). Anti-JNK1 mouse pAb was from Santa Cruz Biotechnology (Santa Cruz, CA), anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mouse mAb was from Abcam (Cambridge, MA), and anti-tubulin mouse mAb was from Developmental Studies Hybridoma Bank, University of Iowa (Iowa City, IA). Mouse NMuMG cells (CRL-1636) were obtained from American Type Culture Collection (Manassas, VA). Subclones of NMuMG cells were prepared by limiting dilution in flat bottom 96-well plates. NMuMG cells and their subclones were maintained in DMEM supplemented with 10% fetal bovine serum (FBS) (Hyclone Laboratories, Logan, UT), 4.5 g/l glucose, and 10 µg/ml insulin. Rat tail collagen type I and bovine fibronectin were from BD Biosciences PharMingen (San Diego, CA) or R&D Systems (Minneapolis, MN), respectively. For preparation of ECM-coated substrates, 100-mm dishes or 22-mm coverslips were incubated overnight at 4°C with collagen I (50 µg/ml) in 0.02 N acetic acid or fibronectin (50 µg/ml) in phosphate-buffered saline (PBS). Dishes or coverslips were then washed twice with PBS, blocked with PBS containing 1% bovine serum albumin for 30 min at room temperature, and washed twice with PBS. Serum was reduced to 1% to examine signals primarily from adhesion to ECM. LY294002, anisomycin (Calbiochem, La Jolla, CA), and SP600125 (BIOMOL Research Laboratories, Plymouth Meeting, PA) were added at the indicated concentrations. For blocking TGF
activity, nonspecific IgG was from Zymed Laboratories, and pan-specific TGF
rabbit pAb was from R&D Systems. For neutralization of TGF
bioactivity, antibody was added to the medium at 10 µg/ml.
Detergent Extraction, SDS-PAGE, and Immunoblots
Monolayers of cultured cells were washed with ice-cold PBS and extracted on ice with radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl, pH 8.0, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 2 mM phenylmethylsulfonyl fluoride [PMSF], and 0.2 U/ml aprotinin). In some experiments, protein was extracted with RIPA buffer containing 2 mM orthovanadate and 20 µM calyculin A. Extracts were centrifuged at 20,000 x g for 15 min at 4°C, and the supernatant was collected. Protein concentration was determined using a Bio-Rad protein assay kit (Bio-Rad, Hercules CA). Cell extracts were resolved by SDS-PAGE (Laemmli, 1970
), immunoblotted as described previously (Johnson et al., 1993
), and quantified by densitometry using Adobe Photoshop (Adobe Systems, Mountain View, CA).
Cell Surface Biotinylation
Cells were grown to subconfluence in 10-cm dishes, washed with PBS, and incubated with the nonmembrane-permeable biotinylation reagent sulfo-N-hydroxysuccinimidobiotin (Pierce Chemical, Rockford, IL) for 20 min on ice. After quenching with media containing 10% FBS and washing with PBS, the cells were lysed directly on the dish with RIPA buffer. Then, 500 µg protein was incubated with anti-E-cadherin (4A2) for 1 h at 4°C with rotation. Antibody affinity gel (goat affinity-purified antibody to mouse IgG; MP Biomedicals, Aurora, OH) was added to the extracts and incubated overnight at 4°C with rotation. The gel was washed three times with lysis buffer, mixed with loading sample buffer, separated by SDS-PAGE, transferred to a nitrocellulose membrane, and probed with horseradish peroxidase-labeled streptavidin (Pierce Chemical).
Cell Fractionation
Cells were grown to subconfluence in 10-cm dishes and lysed for 10 min on ice with gentle rocking in 1% Triton X-100, 50 mM Tris, pH 7.6, 150 mM NaCl, and 2 mM EDTA with protease inhibitors. The lysis buffer removed from the cells constituted the Triton X-100soluble fraction. The remaining cells were lysed with sonication in SDS buffer (50 mM Tris, pH 6.8, 10% glycerol, and 2% SDS) to produce the insoluble fraction. An equal percentage of each fraction was resolved by SDS-PAGE.
Pull-Down Assays
Pull-down assays were performed as described previously (Johnson et al., 2004
). Briefly, cultured cells were rinsed twice with cold PBS and scraped in lysis buffer (50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 10 mM MgCl2, 1 mM dithiothreitol, 1% Nonidet P-40, 5% glycerol, 1 µg/ml leupeptin, 1 µg/ml aprotinin, and 1 mM PMSF). The mixture was incubated on ice for 10 min and clarified by centrifugation. Then, 1 mg of protein was incubated with glutathione S-transferase (GST)-CRIB (Rac1) or GST-WASP (Cdc42) beads (Johnson et al., 2004
) for 1 h at 4°C and centrifuged. The beads were washed three times with lysis buffer and resuspended in 2x Laemmli sample buffer for SDS-PAGE (Laemmli, 1970
).
Immunofluorescence Microscopy
Cells were fixed with HistoChoice tissue fixative (Amresco, Solon, OH) and processed as described previously (Kim et al., 2000
). When staining with phalloidin, cells were fixed in 3.7% formaldehyde for 15 min, and permeabilized with 0.2% Triton X-100 in PBS for 15 min. Cells were examined on an Axiovert 200M microscope (Carl Zeiss, Gottingen, Germany) equipped with an ORCA-ER digital camera (Hamamatsu, Houston, TX). Images were collected and processed using OpenLab software (Improvision, Boston, MA) or SlideBook software (Intelligent Imaging Innovations, Santa Monica, CA).
Conventional Reverse Transcription (RT)-PCR
Total RNA was extracted with TRI reagent and analyzed by RT-PCR using a Titanium One-Step RT-PCR kit (Clontech, Mountain View, CA) and previously reported forward and reverse primers for mouse E-cadherin (Tegoshi et al., 2000
), mouse N-cadherin (Chung et al., 1998
), mouse TGF
(Derynck et al., 1986
), and mouse GAPDH (Xu et al., 2000
). The conditions for PCR were as follows: 94°C for 45 s, 60°C for 30 s, and 72°C for 90 s for 35 cycles for N-cadherin and TGF
or 30 cycles for E-cadherin and GAPDH. PCR products were analyzed by electrophoresis on 1.5% agarose gels.
Quantitative Real-Time RT-PCR
Total RNA was analyzed in an Mx3000P Real-Time PCR system (Stratagene, La Jolla, CA) using the following PCR protocol: 50°C for 30 min and 95°C for 10 min, followed by 50 cycles at 95°C for 15 s and 60°C for 1 min. Combinations of primers and probes for E-cadherin, N-cadherin, and 18S rRNA (control) were purchased from Applied Biosystems (Foster City, CA), and a reaction mixture was made using Brilliant Probe-Based QRT-PCR reagents (Stratagene) according to the manufacturers protocol. Reactions were performed in duplicate and repeated three times, except for the real time PCR shown in Figure 3E, which was repeated two times.
Constructs, Transfections, and Infection
N-terminal green fluorescent protein (GFP)-tagged Rac1N17 and RacV12, kind gifts of Dr. Klaus Hahn (University of North Carolina, Raleigh, NC), and C-terminal myc-tagged human N-cadherin (Kim et al., 2000
) were subcloned into LZRS-MS-Neo (Ireton et al., 2002
). The N-cadherin short hairpin RNA (shRNA) construct in pSuperRetroPuro and the Src dominant negative construct have been described previously (Maeda et al., 2005
). shRNA targets for integrin
1, as suggested by CODEX, were GGAAGGAAATCTTAGCTTT (nucleotides 31343152 of integrin
1 GenBank accession no. NM010578.1). cDNA for mouse Smad7 was generated using RT-PCR and total RNA from NMuMG/E9 cells. Phoenix 293 cells were transfected using a calcium phosphate transfection kit (Stratagene) to produce retroviral particles. Conditioned medium containing recombinant retrovirus and supplemented with 4 µg/ml polybrene was added to cells as described previously (Johnson et al., 2004
; Maeda et al., 2005
). Transfected or infected cells were selected with 1 mg/ml G418 (Cellgro; Mediatech, Herndon, VA) or 4 µg/ml puromycin. N-cadherin and integrin
1 knockdown and control enhanced GFP shRNA was performed as described previously (Maeda et al., 2005
).
Transwell Motility Assays
Cells (5 x 105) were plated in the top chamber of polyethylene terephthalate membranes (BD BioCoat control culture inserts, six-well plates, pore size 8 µm; BD Biosciences, San Jose, CA). Both upper and lower sides of the inserts were coated with collagen I or fibronectin. DMEM, 1% FBS was added to the top chambers, and DMEM, 10% FBS was added to the bottom chamber. For experiments using inhibitors, dimethyl sulfoxide (DMSO), LY294002 (10 µM), or SP600125 (10 µM) were added to both the top and bottom chambers. Cells were incubated on the membranes for 4 h, and cells that did not migrate through the membrane were removed with a cotton swab. Cells traversing the membrane were stained using a HEMA3 stain set and five random fields of view at 100x magnification were counted and expressed as the average number of cells per field of view. Three independent experiments were performed, and the data are represented as the average with SD.
Three-dimensional (3D) Culture in Collagen Gels
Collagen gel cultures were performed as described previously (Montesano et al., 1991
). In brief, 50,000 cells were resuspended in 2 ml of cold collagen solution (1 mg/ml final concentration) in a six-well dish. After the collagen solution had gelled, 2 ml of complete medium was added to each well and changed every 3 d. For inhibitory experiments, LY294002 or SP600125 was added to the complete medium. Quantification of branching was performed by counting all identifiable branch points in each colony as described previously (Soriano et al., 1995
).
Statistical Analysis
Statistical analysis was performed using MannWhitney U- and KruskalWallis tests (StatView version 5.0; Abacus Concepts, Berkeley, CA), with p < 0.05 considered statistically significant.
| RESULTS |
|---|
|
|
|---|
(Maeda et al., 2005When NMuMG/E10 cells were cultured on noncoated dishes or fibronectin-coated dishes, they grew as compact colonies, had well-organized cellcell junctions (Figure 1,a and c), and E-cadherin was localized at cellcell borders (Figure 1, d and f). In contrast, when cultured on collagen I, NMuMG/E10 cells seemed fibroblastic and did not form compact epithelial colonies, but rather, they were scattered, as is typical for cells undergoing EMT (Figure 1b). In addition, E-cadherin staining was reduced at cellcell borders (Figure 1e). To ensure that clone NMuMG/E10 was not unique in its response to ECM, we plated the bulk population of parental cells on noncoated, collagen I-coated, or fibronectin-coated dishes and showed that they responded in a manner similar to the clone. These data are presented as Supplemental Figure S1.
|
|
|
|
and collagen Iinduced changes were actually due to autocrine TGF
signaling, we showed that mRNA for TGF
was not increased when cells were plated on collagen I (Supplemental Figure S2A). In addition, we showed that pan neutralizing antibodies against TGF
did not abolish the effect of plating cells on collagen I (Supplemental Figure S2B). Further evidence that TGF
is not a factor in collagen Iinduced cellular changes comes from the fact that NMuMG/E10 cells plated on collagen I did not show nuclear translocation of Smad2/3 (Supplemental Figure S2C), a hallmark of signaling initiated by all TGF
family members (reviewed in Shi and Massague, 2003
We have previously shown that NMuMG cells induced to undergo EMT by treatment with TGF
down-regulate E-cadherin expression concomitant with up-regulation of N-cadherin. However, in ECM-induced changes in these cells, the E-cadherin protein and mRNA levels were the same after 2 d in cells plated on collagen I-coated dishes as in cells plated on noncoated dishes or fibronectin-coated dishes (Figure 3) and was only slightly reduced after 3 d (Figure 4). Previous studies have shown that expression of the inhibitory Smad, Smad7, prevents TGF
-induced EMT (reviewed in Shi and Massague, 2003
; ten Dijke and Hill, 2004
); however, expression of Smad7 did not prevent collagen Iinduced morphological changes in NMuMG/E10 cells (Supplemental Figure S2D). Thus, the data presented in Figures 1![]()
4 show that NMuMG/E10 cells undergo changes in morphology and cadherin expression in response to collagen I that partially resembles classical EMT and that the response differs from the response of these same cells to TGF
, suggesting that signaling pathways involved in ECM-induced cellular changes differ from those involved in TGF
-induced EMT.
Integrin/Rac1 Signaling Promotes Collagen Iinduced Cell Scattering and Up-Regulation of N-Cadherin
To confirm that integrin engagement is a component of the collagen I-mediated changes in cellular phenotype described above, we investigated the activation state of molecules known to be downstream of integrins by examining phosphorylation of FAK and paxillin. FAK is a protein tyrosine kinase that links integrin receptors to intracellular signaling pathways and is itself phosphorylated when activated (Schlaepfer et al., 1999
). Figure 5A shows that FAK was more highly phosphorylated when NMuMG/E10 cells were plated on collagen I-coated dishes than when they were plated on noncoated dishes or fibronectin-coated dishes. In addition, paxillin, which is downstream of integrin signaling was also more highly phosphorylated in cells cultured on collagen I-coated plates (Figure 5B). To directly investigate the role of integrin in N-cadherin up-regulation and cell scattering in response to collagen I, we used shRNA to knockdown integrin
1 expression in NMuMG/E10 cells and compared the morphology of cells plated on noncoated versus collagen I-coated dishes (Figure 5C). The morphology of the cells did not change when plated on noncoated dishes (Figure 5C, compare c with a). There was a morphological change in the integrin
1-knocked down cells when plated on collagen I-coated dishes versus noncoated dishes (Figure 5C, compare d with c); however, the integrin
1-knocked down cells were less scattered on collagen I than were the controls (Figure 5C, compare d with b). Figure 5D shows that integrin
1 was very effectively knocked down by the shRNA (top) and that knocking down integrin
1 prevented the up-regulation of N-cadherin when the cells are plated on collagen I (middle). These data further implicate integrin
1 in collagen Iinduced cell scattering and N-cadherin up-regulation.
|
|
|
|
N-Cadherin Knockdown Inhibits Collagen I-mediated Cell Scattering
LY294002, RacN17, and SP600125 inhibited both collagen I-mediated morphological changes and N-cadherin up-regulation in NMuMG/E10 cells. Together, these data led us to speculate that up-regulation of N-cadherin itself may promote the morphological changes that occur when NMuMG/E10 cells are plated on collagen I and/or may be essential for these changes. To test this idea, we generated N-cadherin knockdown NMuMG/E10 cells and N-cadherin overexpressing cells (Figure 9B). When cells were cultured on noncoated dishes, the morphology of N-cadherin knockdown and N-cadherin overexpressing cells was almost identical to that of parental NMuMG/E10 cells, in spite of significant differences in N-cadherin expression (Figure 9A). Interestingly, collagen Iinduced cell scattering was inhibited by N-cadherin knockdown (Figure 9A, e) compared with mock-infected NMuMG/E10 cells (Figure 9A, d) or N-cadherin overexpressing cells (Figure 9A, f). In fact, the scattering response of N-cadherin overexpressing cells to collagen I was greater than that of mock-transfected cells (Figure 9A, compare f with d). These data indicate that increased N-cadherin expression specifically promotes cell scattering in response to collagen I and does not promote cell scattering in the absence of collagen I, implying cells must obtain signals from collagen I in conjunction with increased N-cadherin expression to undergo scattering. Interestingly, preventing N-cadherin up-regulation in response to collagen I had no effect on the ability of the cells to activate Rac1, whereas overexpressing N-cadherin resulted in constitutive activation of Rac1, independent of the plating conditions (Figure 9C). This is consistent with previous studies from our laboratory showing that overexpression of another mesenchymal cadherin, R-cadherin, increases steady-state levels of Rac1 (Johnson et al., 2004
).
|
|
1
1 and
2
1 integrins to show that the function of
2
1 integrin, the major receptor for collagen I, is required for branching morphogenesis (Zutter et al., 1999
|
| DISCUSSION |
|---|
|
|
|---|
1 in integrin
1-null epithelial cells resulted in disruption of adherens junctions and loss of cadherin function. In addition, using an oral squamous epithelial cell line that forms multicellular aggregates when plated on nonadherent substrates, Kawano et al. (2001)
Signaling Induced by Plating Cells on Collagen I
To identify pathways that are relevant to collagen Iinduced cellular changes, we investigated signaling events known to be downstream of integrin engagement, including phosphorylation of FAK and paxillin. Each of these integrin-related molecules was more highly phosphorylated when NMuMG/E10 cells were cultured on collagen I-coated plates than when they were cultured on noncoated dishes or fibronectin-coated dishes. FAK colocalizes with integrins in focal contacts, and its phosphorylation, which is induced by integrin occupation and clustering, initiates downstream signaling events (Yamada and Miyamoto, 1995
). Activated FAK is known to bind to c-Src and PI3K, leading to changes in phosphorylation of signaling molecules. Menke et al. (2001)
reported that down-regulation of E-cadherin expression depends on Src activation when plating pancreatic cancer cell lines on collagen I. However, in our system, collagen Iinduced cell scattering and up-regulation of N-cadherin were not inhibited by expression of dominant-negative Src, whereas the PI3K inhibitor LY294002 inhibited both the morphological changes and N-cadherin up-regulation. The product of PI3K activity, phosphatidylinositol 3,4,5-phosphate, is required to regulate many Rac-specific guanine nucleotide exchange factors, including Tiam1 and Vav (Han et al., 1998
; Fleming et al., 2000
), leading to activation of Rac. Thus, PI3K is vital to cell migration in response to integrin signaling (Shaw et al., 1997
). Our results suggest that PI3K plays a key role in collagen I-mediated cellular changes in NMuMG/E10 cells. Bakin et al. (2000)
reported that PI3K-Akt signaling is required for TGF
-induced transcriptional responses, EMT, and cell migration. These authors also showed that inhibiting PI3K blocked TGF
-mediated phosphorylation of Smad2. In our system, Smad2/3 was not translocated to the nucleus when NMuMG/E10 cells were plated on collagen I, and Smad7 overexpression did not inhibit cellular changes in response to collagen I. Thus, the signaling pathways involved in collagen Iinduced cell scattering and up-regulation of N-cadherin are likely different from those activated during TGF
-mediated EMT.
Small GTPases of the Rho family are regulators of the actin cytoskeleton (Mackay and Hall, 1998
). In particular, Rac is a regulator of cell motility, and active Rac localizes at the leading edge of motile cells (Kraynov et al., 2000
; Wojciak- Stothard et al., 2001
). Activation of PI3K by integrin
6
4 stimulates Rac-dependent migration of colon carcinoma cells (Shaw et al., 1997
). In addition, activation of Rac and Cdc42 stimulate the motility of mammary carcinoma cells through PI3K activation (Keely et al., 1997
). Our study provides strong evidence that Rac1 plays a crucial role as a mediator of collagen Iinduced cellular changes in NMuMG/E10 cells because RacN17 inhibited the disruption of cellcell adhesion and cell scattering. These data are consistent with a previous study showing that integrin
1 triggered the activation of Rac1, but not Cdc42 (Gimond et al., 1999
), and suggest that Rac1, but not Cdc42, plays a major role in the regulating collagen Iinduced cell scattering in NMuMG/E10 cells.
It is clear from a number of studies that integrins signal to JNK (Miyamoto et al., 1995
; Mainiero et al., 1997
; Oktay et al., 1999
; Almeida et al., 2000
). For example, Oktay et al. (1999)
used 293 human embryonic kidney cells to show that integrin-mediated stimulation of JNK requires the association of FAK with Src and p130CAS, the phosphorylation of p130CAS, and the recruitment of Crk, whereas PI3K activity was not required (Oktay et al., 1999
). In contrast, integrin-mediated activation of JNK in human keratinocytes requires RasPI3KRac signaling (Mainiero et al., 1997
). In our studies, the PI3K inhibitor LY294002 completely inhibited RacJNK signaling in response to collagen I. Thus, it seems that integrin-mediated JNK activation occurs via different pathways in different cell types.
The study presented here agrees with Sander et al. (1998)
who showed that PI3K regulates cell migration in MDCK cells in a collagen-dependent manner. In their study, Rac activation inhibited motility of MDCK cells plated on fibronectin or laminin by promoting E-cadherin cell-cell contacts, but promoted motility of MDCK cells plated on collagen by preventing E-cadherin contacts. In their system plating cells on collagen also decreased surface E-cadherin without affecting total levels of this protein. A number of studies, including the Sander study, have implicated E-cadherin as a suppressor of cell motility, whereas studies from our laboratory and others have shown that the expression of N-cadherin or other mesenchymal cadherins can promote motility, even in cells that continue to express E-cadherin. Thus, is clear that motility and cadherin function are regulated differently in different cells, and this may be one reason tumor cell invasion and motility are so difficult to decipher (reviewed in Cavallaro et al., 2002
; Cavallaro and Christofori, 2004
).
Phosphorylation of transcription factors by JNK promotes expression of matrix metalloproteinases, which implicates integrinJNK signaling in tumor cell invasion (Davis, 2000
; Schlaepfer et al., 2004
). The current study shows that expression of N-cadherin is up-regulated by collagen I through integrinJNK signaling. Likewise, De Wever et al. (2004)
reported that up-regulation of N-cadherin by TGF
occurs via JNK activation in myofibroblasts. The N-cadherin promoter is reported to have AP1 binding sites (Li et al., 1997
; Le Mee et al., 2005
), and Jun is a member of the activator protein-1 family of transcription factors. In our system, collagen I stimulates JNK activity, likely through integrinRac signaling, which leads to phosphorylation of Jun.
The Role of N-Cadherin Up-Regulation in Collagen Iinduced Phenotypic Changes in NMuMG/E10 Cells
Knocking down N-cadherin in NMuMG/E10 cells interfered with collagen I-mediated morphological changes. We previously showed that knocking down N-cadherin expression did not interfere with TGF
-mediated morphological changes in NMuMG cells (Maeda et al., 2005
), suggesting that different signaling pathways are involved in TGF
and collagen Iinduced cellular changes in NMuMG cells. Furthermore, transwell assays showed that N-cadherinoverexpressing NMuMG/E10 cells were significantly more motile than mock-transfected or N-cadherin knockdown cells in collagen I-coated transwells but not in fibronectin-coated transwells, suggesting that N-cadherin up-regulation is associated specifically with collagen I-mediated cell motility.
Interestingly, N-cadherin knockdown also inhibited cord formation and branching of NMuMG/E10 cells in collagen gels. Soriano et al. (1995)
reported that either conditioned medium from fibroblasts or hepatocyte growth factor-stimulated cord formation by NMuMG cells. Here, we show for the first time that expression of N-cadherin is necessary for formation of these structures and for branching in collagen gels. Our findings suggest that up-regulation of N-cadherin is an important component of ECM-induced cell scattering in cancer progression and may also be important in normal mammary gland development. In conclusion, N-cadherin is up-regulated through PI3KRac1JNK signaling when NMuMG/E10 cells are plated on collagen I, and N-cadherin up-regulation is necessary for increased cell motility in response to collagen I and for generation of cord structures in 3D collagen gels.
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org). ![]()
Address correspondence to: Margaret J. Wheelock ( mwheelock{at}unmc.edu)
| REFERENCES |
|---|
|
|
|---|
Almeida, E. A., Ilic, D., Han, Q., Hauck, C. R., Jin, F., Kawakatsu, H., Schlaepfer, D. D., Damsky, C. H. (2000). Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. J. Cell Biol 149, 741754.
Arregui, C., Pathre, P., Lilien, J., Balsamo, J. (2000). The nonreceptor tyrosine kinase fer mediates cross-talk between N-cadherin and beta1-integrins. J. Cell Biol 149, 12631274.
Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L., Arteaga, C. L. (2000). Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem 275, 3680336810.
Berdichevsky, F., Alford, D., DSouza, B., Taylor-Papadimitriou, J. (1994). Branching morphogenesis of human mammary epithelial cells in collagen gels. J. Cell Sci 107, 35573568.[Abstract]
Bhowmick, N. A., Zent, R., Ghiassi, M., McDonnell, M., Moses, H. L. (2001). Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J. Biol. Chem 276, 4670746713.
Brunton, V. G., MacPherson, I. R., Frame, M. C. (2004). Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry. Biochim. Biophys. Acta 1692, 121144.[Medline]
Cavallaro, U. and Christofori, G. (2004). Cell adhesion and signalling by cadherins and immunoglobulin-CAMs in cancer. Nat. Rev. Cancer 4, 118132.[Medline]
Cavallaro, U., Schaffhauser, B., Christofori, G. (2002). Cadherins and the tumour progression: is it all in a switch? Cancer Lett 176, 123128.[CrossRef][Medline]
Christofori, G. (2003). Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J 22, 23182323.[CrossRef][Medline]
Chung, S. S., Mo, M. Y., Silvestrini, B., Lee, W. M., Cheng, C. Y. (1998). Rat testicular N-cadherin: its complementary deoxyribonucleic acid cloning and regulation. Endocrinology 139, 18531862.
Davis, R. J. (2000). Signal transduction by the JNK group of MAP kinases. Cell 103, 239252.[CrossRef][Medline]
De Wever, O. and Mareel, M. (2003). Role of tissue stroma in cancer cell invasion. J. Pathol 200, 429447.[CrossRef][Medline]
De Wever, O., Westbroek, W., Verloes, A., Bloemen, N., Bracke, M., Gespach, C., Bruyneel, E., Mareel, M. (2004). Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-{beta} or wounding. J. Cell Sci 117, 46914703.
Derycke, L. D. and Bracke, M. E. (2004). N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int. J. Dev. Biol 48, 463476.[CrossRef][Medline]
Derynck, R., Jarrett, J. A., Chen, E. Y., Goeddel, D. V. (1986). The murine transforming growth factor-beta precursor. J. Biol. Chem 261, 43774379.
Finnemann, S., Kuhl, M., Otto, G., Wedlich, D. (1995). Cadherin transfection of Xenopus XTC cells downregulates expression of substrate adhesion molecules. Mol. Cell. Biol 15, 50825091.[Abstract]
Fleming, I. N., Gray, A., Downes, C. P. (2000). Regulation of the Rac1-specific exchange factor Tiam1 involves both phosphoinositide 3-kinase-dependent and -independent components. Biochem. J 351, 173182.[CrossRef][Medline]
Gimond, C., van Der Flier, A., van Delft, S., Brakebusch, C., Kuikman, I., Collard, J. G., Fassler, R., Sonnenberg, A. (1999). Induction of cell scattering by expression of beta1 integrins in beta1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function. J. Cell Biol 147, 13251340.
Guo, W. and Giancotti, F. G. (2004). Integrin signalling during tumour progression. Nat. Rev. Mol. Cell. Biol 5, 816826.[CrossRef][Medline]
Han, J., Luby-Phelps, K., Das, B., Shu, X., Xia, Y., Mosteller, R. D., Krishna, U. M., Falck, J. R., White, M. A., Broek, D. (1998). Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 279, 558560.
Hazan, R. B., Phillips, G. R., Qiao, R. F., Norton, L., Aaronson, S. A. (2000). Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol 148, 779790.